Skip to main content
Scientist with swoosh in background

Welcome to Sphere Fluidics

We're all about bringing together expertise and cutting-edge technology to help our global customers achieve their goals faster and more cost-effectively. We are a world leader in providing droplet microfluidic platforms, consumable products, and collaborative R&D services to enable more effective primary research and the discovery of new therapeutics for improved pharmaceutical production and bioproduction.
Contact Us About Investing

Invest with Confidence

Invest with confidence in Sphere Fluidics – a trusted leader in the biopharmaceutical and cell therapy markets. Our prestigious history as a Cambridge University spin-out combined with our passionate and knowledgeable management team puts us in a unique position to excel in the Life Sciences tools market.

With a proven track record of over 400 international customers, £41 million in investment (from prestigious angel and VC funds), and a portfolio of 135 international patents, we’re now aiming for rapid growth and profitability. Our novel picodroplet-based technologies fill a gap in the market, offering superior ROI with low risk.

We strive to meet consumer needs and develop products that allow our customers to find, analyze and isolate their most valuable cells, with ease and speed. Building on the success of our flagship Cyto-Mine® platform, we’re continuing to invest in our people, our facilities, and product development to successfully integrate cell biology, microfluidics, and cutting-edge engineering into groundbreaking solutions.

We understand the dynamic nature of the industry we serve. Our leaders are constantly looking for new opportunities and key growth markets to move into as part of our iterated strategy, built to minimize risk and maximize opportunity.

Join us at this pivotal point in our development as we continue to scale up and globalize our business.

Company Highlights

tick icon

Over 400 international customers

tick icon

Collaborations with 7 of the world’s top 10 pharma companies

tick icon

A portfolio of 135 international patents

tick icon

Addressing rapidly growing markets of ~$55 billion

Hear from our Chairman

Scientist with swoosh in background

Current Investors

Among our prominent investors are leading venture capital firms, strategic partners, and experienced angel investors who recognize the immense potential of our company. Their invaluable support extends beyond financial backing, as they bring a wealth of industry knowledge, extensive networks, and strategic guidance to our organization.

Scientist with swoosh in background

Explore Investment Opportunities with Sphere Fluidics

The market need is there. The technology is there. The opportunity is there. Will you be a part of it?

Contact us